Amrutanjan Health Care Limited (BOM:590006)

Amrutanjan Health Care Balance Sheet

Financials in millions INR. Fiscal year is April - March.

Assets

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Cash & Equivalents	230.85	112.72	101.55	37.12	49.03	21.86
Short-Term Investments	31.61	1,561	1,851	2,035	1,724	1,940
Trading Asset Securities	-	30.74	-	0.01	51.47	48.49
Cash & Short-Term Investments	262.46	1,705	1,953	2,072	1,825	2,011
Cash Growth	-87.35%	-12.71%	-5.74%	13.54%	-9.26%	14.68%
Accounts Receivable	444.24	606.44	558.22	478.89	330.2	382.56
Other Receivables	-	-	-	-	60.83	-
Receivables	444.24	606.44	558.22	478.89	391.03	382.56
Inventory	580.86	373.5	272.6	289.05	288.25	260.01
Prepaid Expenses	-	19.16	10.61	8.05	3.59	3.59
Other Current Assets	1,764	212.72	112.53	109.18	91.97	89.55
Total Current Assets	3,052	2,916	2,907	2,957	2,599	2,746
Property, Plant & Equipment	1,885	1,553	639.26	495.44	475.45	434.7
Long-Term Investments	0.41	462.38	416.98	117.81	426.5	223.09
Other Intangible Assets	16.05	16.85	17.28	23.78	24.84	23.19
Long-Term Deferred Tax Assets	25.33	53.15	31.12	31.72	42.54	36.42
Other Long-Term Assets	172.02	87.21	202.54	43.15	52.12	34.78
Total Assets	5,151	5,089	4,214	3,669	3,621	3,499

Liabilities

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Accounts Payable	633.89	708.95	690.43	558.63	474.36	604.49
Accrued Expenses	-	108.94	104.38	92.66	87.63	52.13
Current Portion of Leases	3.66	3.54	4.02	3.32	5.05	5.69
Current Income Taxes Payable	57.21	50.73	16.72	16.22	32.54	31.85
Other Current Liabilities	488.51	389.68	30.29	28.37	30.55	80.57
Total Current Liabilities	1,183	1,262	845.83	699.19	630.12	774.73
Long-Term Leases	15.25	14.23	16.76	13.97	4.04	3.11
Pension & Post-Retirement Benefits	-	81.94	66.84	55.94	57.47	47.35
Other Long-Term Liabilities	112.98	28.56	18.3	14.73	21.58	22.26
Total Liabilities	1,311	1,387	947.73	783.82	713.21	847.44

Shareholders' Equity

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Common Stock	28.91	28.91	28.91	28.91	29.23	29.23
Retained Earnings	-	3,685	3,241	2,873	2,910	2,658
Treasury Stock	-	-8.97	-10.61	-16.18	-44.57	-44.98
Comprehensive Income & Other	3,810	-2.93	7.33	-0.93	13.21	8.83
Shareholders' Equity	3,839	3,702	3,266	2,885	2,908	2,651
Total Liabilities & Equity	5,151	5,089	4,214	3,669	3,621	3,499

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Sep 30, 2026	Mar 31, 2026	Mar 31, 2025	Mar 31, 2024	Mar 31, 2023	Mar 31, 2022
Total Debt	18.9	17.77	20.78	17.28	9.09	8.8
Net Cash (Debt)	243.56	1,687	1,932	2,054	1,816	2,002
Net Cash Growth	-88.15%	-12.69%	-5.96%	13.15%	-9.31%	15.06%
Net Cash Per Share	8.43	58.35	66.83	70.79	62.12	68.47
Filing Date Shares Outstanding	28.9	28.91	28.91	28.91	29.23	29.23
Total Common Shares Outstanding	28.9	28.91	28.91	28.91	29.23	29.23
Working Capital	1,868	1,655	2,061	2,258	1,969	1,972
Book Value Per Share	132.87	128.06	112.97	99.79	99.48	90.70
Tangible Book Value	3,823	3,685	3,249	2,861	2,883	2,628
Tangible Book Value Per Share	132.31	127.48	112.38	98.96	98.63	89.91
Land	-	22.15	22.15	22.15	23.17	23.17
Buildings	-	243.87	238.1	224.57	220.74	178.65
Machinery	-	550.01	481.56	441.17	439.72	250.81
Construction In Progress	-	1,055	161.98	23.45	11.14	162.65
Leasehold Improvements	-	3.69	3.69	2.53	0.2	0.2

Data Source: S&P Global Market Intelligence Last updated: Nov 3, 2026

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Nov 7, 2026

Data Sources Report a data error